NCT04439721View on ClinicalTrials.gov

γδT Cell Infusion to Prevent Relapsed/Refractory Leukemia Rescue Relapse

EARLY_PHASE1UnknownINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

May 1, 2021

Study Completion Date

May 1, 2021

Conditions
Leukemia, B-cell
Interventions
DRUG

γδT Cell infusion agent

γδT

Trial Locations (1)

215006

RECRUITING

No.188 Shizi Street, Suzhou

Sponsors
All Listed Sponsors
collaborator

The First Affiliated Hospital of Soochow University

OTHER

lead

PersonGen BioTherapeutics (Suzhou) Co., Ltd.

INDUSTRY